FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Guanfacine Hydrochloride Tablets
Status: Currently in Shortage
»Date first posted: 10/24/2017
»Therapeutic Categories: Cardiovascular

Expand all

Amneal Pharmaceutical (New 10/24/2017)

Company Contact Information:
877-835-5472

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10) Currently out of stock; Estimated recovery:TBD Other
2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50) Currently out of stock; Estimated recovery:TBD Other

Mylan Pharmaceuticals Inc. (Revised 11/13/2017)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg (NDC 0378-1160-01) Available Other
2 mg (NDC 0378-1190-01) Available Other

Teva Pharmaceuticals (Revised 11/13/2017)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1mg tablets 100 count bottle (NDC 0591-0444-01) Teva is currently experiencing back orders. Resupply expected in late November 2018 with low inventory until at least Q1 2018. Teva currently cannot support increases due to capacity constraints. Demand increase for the drug
2 mg tablets 100 count bottle (NDC 0591-0453-01) Teva has no current back order projections and resupply in late November 2018 will have over 30 Weeks Of Supply. Teva can only support small increases in demand due to capacity constraints Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English